Loading...
Pharmaron Beijing Co., Ltd.
3759.HK•HKSE
Healthcare
Biotechnology
HK$15.94
HK$0.36(2.31%)
Pharmaron Beijing Co., Ltd. (3759.HK) AI-Powered Stock Analysis
See how Pharmaron Beijing Co., Ltd. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerPharmaron Beijing Co., Ltd. (3759.HK) Stock Overall Grade
Pharmaron Beijing Co., Ltd.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B+
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Pharmaron Beijing Co., Ltd.'s overall stock rating.
Forecast
BScore
60/100Financial Growth
A+Score
95/100Fundamental Growth
BScore
62/100Key Ratios
B+Score
78/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
75/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
50/100Component Analysis Explained
Understand the key factors behind each Pharmaron Beijing Co., Ltd. stock grade, including financials, comparisons, and forecasts.